This article describes vignettes concerning interactions with Data Safety Monitoring Boards during the design and monitoring of some clinical trials with an adaptive design. Most reflect personal experiences by the author.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1740774516689261 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!